FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for ZYPREXA INTRAMUSCULAR (olanzapine) from Eli Lilly and Company, adding the intramuscular formulation to its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• ZYPREXA INTRAMUSCULAR (olanzapine)

Snippet

SUPPL AP for ZYPREXA INTRAMUSCULAR (OLANZAPINE)